7.33
Precedente Chiudi:
$7.44
Aprire:
$7.48
Volume 24 ore:
307.06K
Relative Volume:
1.31
Capitalizzazione di mercato:
$284.30M
Reddito:
$214.30M
Utile/perdita netta:
$10.43M
Rapporto P/E:
28.19
EPS:
0.26
Flusso di cassa netto:
$3.51M
1 W Prestazione:
+13.64%
1M Prestazione:
+8.75%
6M Prestazione:
-8.26%
1 anno Prestazione:
+3.39%
Viemed Healthcare Inc Stock (VMD) Company Profile
Nome
Viemed Healthcare Inc
Settore
Industria
Telefono
337.504.3802
Indirizzo
625 E. KALISTE SALOOM RD., LAFAYETTE
Confronta VMD con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
VMD
Viemed Healthcare Inc
|
7.33 | 282.75M | 214.30M | 10.43M | 3.51M | 0.26 |
![]()
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
![]()
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Viemed Healthcare Inc Stock (VMD) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-03-05 | Iniziato | RBC Capital Mkts | Outperform |
Viemed Healthcare Inc Borsa (VMD) Ultime notizie
How to read the order book for Viemed Healthcare Inc.Wealth Accumulation Outlook for Safe Investors - Newser
Measuring Viemed Healthcare Inc.’s beta against major indicesFree Pattern Alert With ROI Driven Strategy - Newser
Ranking Viemed Healthcare Inc. among high performing stocks via toolsStock Performance Summary Over One Year - Newser
Is this a good reentry point in Viemed Healthcare Inc.Buy and Hold Return Summary with Charts - Newser
What analysts say about Viemed Healthcare Inc. stock outlookEntry Confirmation Using Short-Term Forecasting - Newser
Spotlight On Viemed Healthcare And 2 Other Top Growth Stocks With Insider Confidence - simplywall.st
Viemed Healthcare, Inc. (NASDAQ:VMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Can technical indicators confirm Viemed Healthcare Inc.’s reversalFree Investment Plan With Growth Optimization - Newser
Published on: 2025-08-12 00:31:07 - Newser
How Viemed Healthcare Inc. stock performs during market volatilityStock Price Prediction Using AI Tools - Newser
Viemed Healthcare Inc. Stock Performance After Earnings: Historical InsightsAI Intraday Market Movement Prediction Tool - Newser
Full technical analysis of Viemed Healthcare Inc. stockDaily Stock Forecast Powered by AI Tools - Newser
Will Viemed Healthcare Inc. see short term momentumTrading Volume Anomaly Summary and Insight - Newser
Will Viemed Healthcare Inc. Stock Benefit from AI and Green Energy TrendsRisk/Reward Optimization Entry Point Analysis - Newser
Viemed Healthcare Announces Second Quarter 2025 Financial Results - The Florida Times-Union
Viemed Healthcare's Q2 2025: Unraveling Key Contradictions on VA Opportunities, Staffing Revenue, and Market Dynamics - AInvest
Viemed Healthcare's Strategic Diversification and Operational Resilience in Q2 2025: A Blueprint for Long-Term Value Creation - AInvest
Viemed Healthcare, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:VMD) - Seeking Alpha
Viemed Healthcare Inc (VMD) Q2 2025 Earnings Call Highlights: Strong Organic Growth and ... - ca.finance.yahoo.com
Viemed Healthcare Inc (VMD) Q2 2025 Earnings Call Highlights: St - GuruFocus
Viemed Healthcare Reports Strong Q2 2025 Growth - TipRanks
Viemed Healthcare Achieves Record Q2 2025 Revenues and Expands Guidance - The Globe and Mail
Viemed Healthcare shares rise 8.53% intraday after Q2 revenue increased 14.7%. - AInvest
Viemed VMD Q2 2025 Earnings Call Transcript - The Globe and Mail
Viemed Healthcare 2025 Q2 Earnings Strong Performance as Net Income Surges 120% - AInvest
Viemed (VMD) Q2 Revenue Rises 15% - The Globe and Mail
Viemed Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Viemed Healthcare Inc Q2 2025 Earnings: EPS of $0.08 and Revenue of $63.1 Million Meet Analyst Estimates - GuruFocus
Viemed Healthcare Announces Second Quarter 2025 Financial Results | VMD Stock News - GuruFocus
Viemed Healthcare Hits Record $63M Revenue as Patient Base Surges 51%, Boosts Full-Year Guidance - Stock Titan
Viemed Healthcare Inc. stock momentum explainedStable Swing Setup with Safety Analysis - Newser
Heatmap analysis for Viemed Healthcare Inc. and competitorsPredictive Analytics for Equity Growth Potential - Newser
TruMerit Launches Global Credential for First-Level, General Nurses - Amarillo Globe-News
Fibonacci Levels Suggest Recovery for Viemed Healthcare Inc.Weekly Hot Picks With Buy Confidence Released - beatles.ru
What makes Viemed Healthcare Inc. stock price move sharplyAI Powered Stock Trend Prediction Model - Newser
What analysts say about Viemed Healthcare Inc. stockConsistent high-performance stocks - Jammu Links News
Should I hold or sell Viemed Healthcare Inc. stock in 2025Capitalize on emerging investment opportunities - Jammu Links News
How volatile is Viemed Healthcare Inc. stock compared to the marketMaximize your returns with smart trade entries - Jammu Links News
Why is Viemed Healthcare Inc. stock attracting strong analyst attentionInvest confidently with professional advice - Jammu Links News
How strong is Viemed Healthcare Inc. company’s balance sheetInvest like a pro with expert recommendations - Jammu Links News
What catalysts could drive Viemed Healthcare Inc. stock higher in 2025Get professional guidance for market timing - Jammu Links News
How does Viemed Healthcare Inc. generate profit in a changing economyDiscover stocks with strong growth potential - Jammu Links News
Viemed Healthcare Inc Azioni (VMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Viemed Healthcare Inc Azioni (VMD) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Moore Michael | President |
Jun 27 '25 |
Option Exercise |
1.81 |
3,486 |
6,310 |
180,919 |
Moore Michael | President |
Jun 30 '25 |
Sale |
6.92 |
177,830 |
1,231,091 |
177,433 |
Moore Michael | President |
Jun 27 '25 |
Sale |
7.00 |
3,486 |
24,402 |
177,433 |
Kaushal Nitin | Director |
Jun 30 '25 |
Option Exercise |
6.63 |
7,048 |
46,728 |
133,891 |
Kaushal Nitin | Director |
Jun 30 '25 |
Sale |
6.91 |
7,048 |
48,702 |
126,843 |
Kaushal Nitin | Director |
Jun 27 '25 |
Option Exercise |
6.63 |
34,100 |
226,083 |
160,943 |
Kaushal Nitin | Director |
Jun 26 '25 |
Option Exercise |
6.63 |
8,852 |
58,689 |
135,695 |
Kaushal Nitin | Director |
Jun 27 '25 |
Sale |
7.01 |
34,100 |
239,041 |
126,843 |
Kaushal Nitin | Director |
Jun 26 '25 |
Sale |
7.00 |
8,852 |
61,964 |
126,843 |
Smokoff Timothy | Director |
Mar 13 '25 |
Sale |
7.69 |
8,865 |
68,174 |
82,786 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):